International variations in trust in health care systems.


Journal

The International journal of health planning and management
ISSN: 1099-1751
Titre abrégé: Int J Health Plann Manage
Pays: England
ID NLM: 8605825

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 09 11 2017
accepted: 04 07 2018
pubmed: 16 8 2018
medline: 3 9 2019
entrez: 16 8 2018
Statut: ppublish

Résumé

Public trust in health care systems has been measured in many countries, but there have been few studies of the intercountry variability in trust, or the degree to which such variability is because of population or structural characteristics. We used data from the health care survey conducted by the International Social Survey Program from 2011 to 2013 in 31 countries to assess whether intercountry variability was significantly greater than intracountry variability using general linear models in which country was treated as a fixed factor. We also assessed the extent to which intercountry variability was because of respondent and economic circumstances (gross national income per capita). Public trust in the health care system varied significantly across countries (P < .001), even after adjustment for 8 within-country predictors and gross national income per capita. One of the strongest predictors of trust was the respondents' most recent health care experience. Higher respondent education, urban residence, and a lower country's gross national income predicted less trust in the health care system. After countries with the 10% highest health expenditures per capita (United States) and the 10% lowest health care expenditures per capita (China and the Philippines) were removed, public trust in the health care system was positively associated with the remaining countries' health care expenditures per capita (Pearson correlation coefficient, 0.490; P = .008) and gross national income per capita (Pearson correlation coefficient, 0.495; P = .007). There is significant variation in public trust in health care across the countries studied. The intercountry differences are due, in part to economic circumstances.

Identifiants

pubmed: 30109894
doi: 10.1002/hpm.2597
doi:

Types de publication

Journal Article

Langues

eng

Pagination

130-139

Subventions

Organisme : Shanghai Jiao Tong University-Yale University Joint Center for Health Policy
Organisme : SMC-Chenxing Scholarship of Shanghai Jiao Tong University

Informations de copyright

© 2018 John Wiley & Sons, Ltd.

Auteurs

Dahai Zhao (D)

School of International and Public Affairs, Shanghai Jiao Tong University, Shanghai, China.

Hongyu Zhao (H)

Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA.

Paul D Cleary (PD)

Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH